Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
9
×
life sciences
national blog main
startups
9
×
boston top stories
boston
deals
investing
national top stories
new york blog main
new york top stories
fda
venture capital
clinical trials
financing
ipo
medical device
san francisco blog main
san francisco top stories
asklepios biopharmaceutical
biogen
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
drug discovery
funding
indiana blog main
indiana top stories
lyra therapeutics
national
novartis
perceptive advisors
pfizer
ptc therapeutics
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
What
new
9
×
drugs
medicines
developing
therapeutics
address
aims
approach
bio
biotech
called
capital
develop
device
disease
ipo
neuro
raised
research
roundup
venture
absorb
activity
adds
ago
allosteric
approvals
associated
backed
bags
bails
based
biogen
biotechs
body
brain
brand
bridgebio
builds
car
Language
unset
9
×
Current search:
new
×
startups
×
unset
×
" boston blog main "
×
@xconomy.com
4 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further